Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Bias of the Immune Response to Pneumocystis murina Does Not Alter the Ability of Neonatal Mice to Clear the Infection.

Autor: Kurkjian C; Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY 40536, USA., Hollifield M; Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY 40536, USA., Feola DJ; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA., Garvy BA; Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.; Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.; Veteran's Affairs Medical Center, Lexington, KY 40502, USA.

Publikováno v: Journal of fungi (Basel, Switzerland) [J Fungi (Basel)] 2021 Oct 02; Vol. 7 (10). Date of Electronic Publication: 2021 Oct 02.

The Distribution and Predictive Factor of Extra-Pancreatic Malignancy Occurrence in Patients with Pancreatic Intraductal Papillary Mucinous Neoplasm—A Ten-Year Follow-Up Case–Control Study in Taiwan.

Autor: Wang, Sheng-Fu^1,2 (AUTHOR) shanelily@msn.com, Wu, Chi-Huan^1,2 (AUTHOR) b9002076@adm.cgmh.org.tw, Sung, Kai-Feng^1,2 (AUTHOR) flying@cgmh.org.tw, Tsou, Yung-Kuan^1,2 (AUTHOR) linchehui@adm.cgmh.org.tw, Lin, Cheng-Hui^1,2 (AUTHOR) r5266@adm.cgmh.org.tw, Lee, Mu-Hsien^1,2 (AUTHOR) milk1372@cgmh.org.tw, Liu, Nai-Jen^1,2 (AUTHOR)

Publikováno v: Cancers. Dec2024, Vol. 16 Issue 23, p4102. 13p.

TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies.

Autor: Burris, Howard, Kurkjian, C., Hart, L., Pant, S., Murphy, P., Jones, S., Neuwirth, R., Patel, C., Zohren, F., Infante, J., Burris, Howard A 3rd, Kurkjian, C D, Murphy, P B, Jones, S F, Patel, C G, Infante, J R

Publikováno v: Cancer Chemotherapy & Pharmacology; Aug2017, Vol. 80 Issue 2, p261-273, 13p

P1.01-113 Phase 1b Trial of Cabozantinib or Cabozantinib Plus Atezolizumab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Autor: Lim, F., Ponce, S., Patel, S., Van Herpen, C., Kurkjian, C., Lou, Y., Liu, Y., Ramsingh, G., Pal, S., Neal, J.

Publikováno v: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S405-S406